§ Funding Round
Series C funding round for Generate Biomedicines raising $270M in September 2023
Series C funding round for Generate Biomedicines raising $270M in September 2023
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
Flagship Pioneering | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | Tony Xu | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Fidelity Management & Research Company | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
T. Rowe Price Associates | — | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$640M
Top Valuation
-
Generate Biomedicines raised $270M in a Series C round.
The round was announced on 09/01/23.
